← All Yield10 Bioscience, INC filings

Yield10 Bioscience, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
YTENQ
Yield10 Bioscience, INC
10-Q: Yield10 Bioscience Reports Q2 2024 Results, Focuses on Asset Sale to Nufarm
Yield10 Bioscience announced its Q2 2024 financial results and is focusing on a potential asset sale to Nufarm, while managing its limited cash resources.
OTC.Pink
YTENQ
Yield10 Bioscience, INC
10-Q: Yield10 Bioscience Reports Q1 2024 Results, Focuses on Sustainable Camelina Products Amidst Financial Challenges
Yield10 Bioscience reported its Q1 2024 financial results, highlighting a focus on commercializing sustainable Camelina products while navigating financial constraints and Nasdaq delisting.